These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11780576)

  • 1. Hamycin therapy of murine disseminated candidiasis: efficacy and interaction with fluconazole.
    Dhuley JN
    Rocz Akad Med Bialymst; 2001; 46():326-33. PubMed ID: 11780576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saperconazole therapy of murine disseminated candidiasis: efficacy and interactions with amphotericin B.
    Sugar AM; Salibian M; Goldani LZ
    Antimicrob Agents Chemother; 1994 Feb; 38(2):371-3. PubMed ID: 8192469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hamycin treatment of candidiasis in normal and diabetic rats.
    Dhuley JN
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):175-80. PubMed ID: 10536305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis.
    Lee JH; Jang EC; Han Y
    Arch Pharm Res; 2011 Mar; 34(3):399-405. PubMed ID: 21547671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal hamycin in the control of experimental aspergillosis in mice: relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin.
    Moonis M; Ahmad I; Bachhawat BK
    Indian J Biochem Biophys; 1992 Aug; 29(4):339-45. PubMed ID: 1427960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo.
    Mehta RT; McQueen TJ; Keyhani A; Lopez-Berestein G
    J Infect Dis; 1991 Nov; 164(5):1003-6. PubMed ID: 1940451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/C mice.
    Moonis M; Ahmad I; Bachhawat BK
    J Drug Target; 1993; 1(2):147-55. PubMed ID: 8069553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of hamycin, a polyene antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.
    Dhuley JN
    Rocz Akad Med Bialymst; 2000; 45():19-25. PubMed ID: 11712431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis.
    Serena C; Rodríguez MM; Mariné M; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):877-9. PubMed ID: 18276603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
    de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
    Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis.
    Graybill JR; Bocanegra R; Luther M
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):700-3. PubMed ID: 8565989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis.
    Koray M; Ak G; Kurklu E; Issever H; Tanyeri H; Kulekci G; Guc U
    Oral Dis; 2005 Sep; 11(5):309-13. PubMed ID: 16120118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
    J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment strategies for disseminated candidiasis.
    Spellberg BJ; Filler SG; Edwards JE
    Clin Infect Dis; 2006 Jan; 42(2):244-51. PubMed ID: 16355336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fluconazole treatment on tumor necrosis factor-alpha production in murine candidiasis.
    Kalkanci A; Kustimur S
    Yale J Biol Med; 2002; 75(5-6):241-5. PubMed ID: 14580106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.